Dr. Douglas Adams, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $253,041 | 103 | 99.9% |
| Travel and Lodging | $232.99 | 2 | 0.1% |
| Food and Beverage | $80.37 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $166,559 | 70 | $0 (2024) |
| Shire North American Group Inc | $86,715 | 35 | $0 (2019) |
| AtriCure, Inc. | $80.37 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,523 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($35,523) |
| 2023 | $32,774 | 15 | Takeda Pharmaceuticals U.S.A., Inc. ($32,774) |
| 2022 | $34,363 | 16 | Takeda Pharmaceuticals U.S.A., Inc. ($34,363) |
| 2021 | $31,200 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($31,200) |
| 2020 | $32,700 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($32,700) |
| 2019 | $31,496 | 15 | Shire North American Group Inc ($31,415) |
| 2018 | $28,900 | 10 | Shire North American Group Inc ($28,900) |
| 2017 | $26,400 | 11 | Shire North American Group Inc ($26,400) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 08/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 01/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $323.08 | General |
| 01/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 12/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 11/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 10/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 09/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 09/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $807.70 | General |
| 07/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 06/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 05/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 04/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $4,900.00 | General |
| 04/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 03/03/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
About Dr. Douglas Adams, M.D
Dr. Douglas Adams, M.D is a Preventive Medicine/Occupational Environmental Medicine healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1538284674.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Adams, M.D has received a total of $253,355 in payments from pharmaceutical and medical device companies, with $35,523 received in 2024. These payments were reported across 106 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($253,041).
Practice Information
- Specialty Preventive Medicine/Occupational Environmental Medicine
- Location Greensboro, NC
- Active Since 03/20/2007
- Last Updated 07/08/2007
- Taxonomy Code 2083P0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538284674
Products in Payments
- ATRICURE CRYOSURGICAL SYSTEM (Device) $80.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.